Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosylate plus sufentanil for sedation in hysteroscopic surgery
ChiCTR2000037813Phase 4Recruiting
- Sponsor
- Jiangyin People's Hospital
- Start
- Sep 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and sufentanil in hysteroscopic surgery (2 arms), sponsored by Jiangyin People's Hospital. Primary endpoints: Induction time, Recovery time and 1 more. Started Sep 2020; status: recruiting.
02
Drugs
remimazolamsufentanil
03
Conditions
hysteroscopic surgery
Beyond the preview
Go deeper on ChiCTR2000037813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000037813.